Analyst firms · BTIG · STAA
BTIG STAA price target and rating history
STAAR Surgical Company (STAA) · Health Care
BTIG rates STAAR Surgical Company (STAA) Neutral with a $46 price target, as of its latest action on Feb 12, 2025. It has published 5 rating actions on STAA since March 2022, including 2 upgrades and 2 downgrades. Across 5 firms with a STAA price target in the last 12 months, the median target is $27.
- Current rating
- Neutral
- Price target
- $46
- Median target, all firms
- $27
- Actions on STAA
- 5
BTIG price target on STAA
Every BTIG rating on STAA
- Feb 12, 2025DowngradeBTIG downgrades to Neutral from Buy
- Jun 11, 2024
- Feb 6, 2023DowngradeBTIG downgrades to Neutral from Buy
- Dec 28, 2022
- Mar 18, 2022
How other firms rate STAA
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Stifel | Buy | $31 | Sep 29, 2026 |
| UBS | Sell | $20 | Jul 28, 2026 |
| Wedbush | Outperform | $40 | May 14, 2026 |
| Canaccord Genuity | Buy | $27 | Apr 9, 2026 |
| Morgan Stanley | Underweight | $13 | Jan 16, 2026 |
Questions about BTIG and STAA
- What is BTIG's price target for STAA?
- BTIG's latest stated price target for STAAR Surgical Company (STAA) is $46, from its action on Jun 11, 2024.
- What is BTIG's rating on STAA?
- BTIG rates STAA Neutral, a neutral rating, as of Feb 12, 2025.
- When did BTIG last change its view on STAA?
- On Feb 12, 2025, BTIG downgrades to Neutral from Buy.
- How does BTIG's STAA target compare with other analysts?
- Across 5 firms with a STAA price target in the last 12 months, the median target is $27.
More STAA rating histories
All BTIG ratingsSTAA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.